French national cohort of neuroendocrine cell hyperplasia of infancy (FRENCHI) study: diagnosis and initial management
Authors:
- Candice FabreCFCandice Fabre
- Caroline ThumerelleCTCaroline Thumerelle
- Morgane DervauxMDMorgane Dervaux
- Rola Abou-TaamRARola Abou-Taam
- Tiphaine BihoueeTBTiphaine Bihouee
- Jacques BrouardJBJacques Brouard
- Annick ClementACAnnick Clement
- Christophe DelacourtCDChristophe Delacourt
- Céline DelestrainCDCéline Delestrain
- Ralph EpaudRERalph Epaud
- Sofiane GhdifanSGSofiane Ghdifan
- Alice HadchouelAHAlice Hadchouel
- 9 June 2022
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 181 (8) , 3067-3073
Abstract
Early diagnosis of neuroendocrine cell hyperplasia of infancy (NEHI) is crucial as, conversely to the other causes of intersititial lung disease, corticosteroids are not recommended. Diagnosis is historically based on lung biopsy (NEHI), but in current practice, a clinical and radiological approach is more and more preferred (NEHI syndrome). This national study aimed to address diagnosis and initial management of patients followed up for a NEHI pattern in pediatric centers for rare lung diseases (RespiRare, France). Data on neonatal and familial events, symptoms at diagnosis, explorations performed and results, and therapeutic management were collected by questionnaire. Fifty-four children were included (boys 63%). The mean onset of symptoms was 3.8 ± 2.6 months. The most frequent symptoms at diagnosis were tachypnea (100%), retraction (79.6%), crackles (66.7%), and hypoxemia (59.3%). The mean NEHI clinical score, evocative when ≥ 7/10, was 7.9 ± 1.4 (76% with a score ≥ 7). All chest CT-scans showed ground glass opacities evolving at least the middle lobe and the lingula. Lung biopsy was performed in 38.9% of the cases and was typical of NEHI in only 52.4%, even when the clinical presentation was typical. Initial treatments were oxygen (83.6%) and more curiously intravenous pulses of steroids (83.3%) and azithromycin (70.2%). Conclusion: This national cohort of patients underlines diagnosis difficulties of NEHI. A composite clinical and radiological score should help clinicians for limiting the use of anti-inflammatory drugs. What is Known: •Neuroendocrine cell hyperplasia of infancy (NEHI) is an interstitial lung disease whose diagnosis is essential to limit corticosteroids therapy. What is New: •In this national cohort of 54 patients with a NEHI pattern, diagnosis is mainly based on clinical symptoms and chest CT-scan results. The newly proposed clinical score and, when performed, the lung biopsies are faulted in 25 and 50% of the cases, respectively. •Corticosteroids are widely used. Such results plead for a new composite score to formally diagnose NEHI.Keywords
This publication has 29 references indexed in Scilit:
- Bombesin staining in neuroendocrine cell hyperplasia of infancy (NEHI) and other childhood interstitial lung diseases (chILD)Histopathology, 2015
- A Mutation in TTF1/NKX2.1 Is Associated With Familial Neuroendocrine Cell Hyperplasia of InfancyChest, 2013
- Diagnostic criteria and follow-up in neuroendocrine cell hyperplasia of infancy: a case seriesJornal Brasileiro de Pneumologia, 2013
- Bronchoalveolar lavage fluid cytokine profiles in neuroendocrine cell hyperplasia of infancy and follicular bronchiolitisOrphanet Journal of Rare Diseases, 2013
- Neuroendocrine cell hyperplasia of infancy: a prospective follow-up of nine childrenArchives of Disease in Childhood, 2012
- A national internet-linked based database for pediatric interstitial lung diseases: the French networkOrphanet Journal of Rare Diseases, 2012
- Neuroendocrine Cell Distribution and Frequency Distinguish Neuroendocrine Cell Hyperplasia of Infancy From Other Pulmonary DisordersChest, 2011
- Neuroendocrine Cell Hyperplasia of Infancy: Diagnosis With High-Resolution CTAmerican Journal of Roentgenology, 2010
- Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolismThorax, 2009
- Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasiaPediatric Pulmonology, 2005